MLF1

MLF1 is a cytoplasmic–nuclear shuttling protein that links subcellular compartmentalization to control of cell proliferation, differentiation, apoptosis, and chromatin-based gene regulation (PMID:17967869). It carries a functional nuclear export signal whose disruption enhances its antiproliferative activity, indicating that cytoplasmic retention restrains its growth-suppressive function (PMID:17967869). MLF1 stabilizes p53 by suppressing the COP1 E3 ubiquitin ligase through the COP9 signalosome subunit CSN3, thereby coupling MLF1 localization to the p53-dependent response to genotoxic and oncogenic stress (PMID:17967869). In the nucleus, MLF1 acts as a transcriptional activator that recruits the acetyltransferase EP300 to target promoters to deposit H3K27ac and open chromatin at senescence effector loci such as IL1B and p21, a function that is EP300- but not PRC2-dependent (PMID:39657728). At mitochondria, MLF1 physically associates with HAX1 and HtrA2, displacing HtrA2 from the pro-survival HAX1/HtrA2/PARL (HOP) complex to promote apoptosis; deletion of Mlf1 rescues lymphopenia and neurodegeneration in Hax1-deficient mice (PMID:28137643). MLF1 also engages 14-3-3ε through a phosphoserine motif at Ser34, resolved by crystallography (PMID:22151054). The leukemogenic NPM-MLF1 fusion redirects MLF1 to the nucleus and nucleolus, abolishing its growth-suppressing and p53-stabilizing activities and instead promoting transformation through aberrant recruitment of the NuRD chromatin remodeling complex (PMID:8570204, PMID:17967869, PMID:31675375).

1. 1996 Medium

   Established that the difference between normal MLF1 and its leukemic fusion is one of localization—wild-type MLF1 is cytoplasmic while NPM-MLF1 is mislocalized to the nucleus and nucleolus—framing aberrant compartmentalization as central to its oncogenic conversion.

   Evidence Immunostaining of t(3;5)-positive leukemia cells and cell lines expressing wild-type MLF1 versus NPM-MLF1

   PMID:8570204

   Open questions at the time

   • Did not define the molecular consequence of mislocalization
   • No identification of MLF1's normal cytoplasmic function
2. 1997 Medium

   Mapped the NPM-derived determinants of the fusion, showing MNDA binds NPM residues 117-175 retained in NPM-MLF1, distinguishing it from NPM-ALK and beginning to define fusion-specific protein interactions.

   Evidence In vitro binding assay and co-immunoprecipitation with domain-mapped NPM fragments

   PMID:9328447

   Open questions at the time

   • Functional consequence of MNDA binding to NPM-MLF1 not established
   • Binding concerns NPM portion, not MLF1 sequences
3. 1999 Medium

   Defined a pro-apoptotic activity of the NPM-MLF1 fusion requiring the MLF1 N-terminus and NPM NLS/dimerization domains, and showed Bcl-2 rescues without altering fusion expression, placing the death phenotype downstream of mitochondrial apoptotic control.

   Evidence Ectopic overexpression and deletion-mutant analysis in K562 and NIH3T3 cells with Bcl-2 co-expression

   PMID:10391679

   Open questions at the time

   • Apoptotic mechanism not molecularly resolved
   • Relationship of fusion-induced death to native MLF1 function unclear
4. 1999 Medium

   Showed the murine homologue HLS7 enforces erythroid-to-myeloid lineage switching without disrupting erythropoietin signaling, establishing MLF1 as a regulator of hematopoietic differentiation rather than a signaling effector.

   Evidence Enforced expression in murine erythroleukemic lines, colony cultures, and EPO signaling assays

   PMID:10523300

   Open questions at the time

   • Molecular targets of the lineage-switch activity not identified
   • Mechanism linking MLF1 to transcriptional/differentiation programs unknown at this stage
5. 2004 Medium

   Identified MLF1IP as a direct binding partner colocalizing in both nucleus and cytoplasm, expanding the MLF1 interactome and reinforcing its dual-compartment biology.

   Evidence Yeast two-hybrid, in vitro pulldown, and co-localization by immunofluorescence

   PMID:15116101

   Open questions at the time

   • Functional role of the MLF1-MLF1IP interaction undefined
   • No pathway placed for MLF1IP
6. 2007 High

   Demonstrated MLF1 is an active nuclear-export-driven shuttling protein and connected its localization to growth control and p53 stabilization via CSN3-mediated suppression of COP1, providing the first mechanistic explanation for both its tumor-suppressive role and the loss of that role upon nucleolar sequestration by NPM.

   Evidence Leptomycin B treatment, NES mutagenesis, subcellular localization, genetic epistasis, and Ras transformation assays in MEFs and hematopoietic cells

   PMID:17967869

   Open questions at the time

   • Direct biochemical demonstration of MLF1-CSN3 and CSN3-COP1 contacts not fully resolved
   • Identity of factors gating MLF1 nuclear import not defined
7. 2012 High

   Resolved the structural basis of the MLF1–14-3-3ε interaction, defining a phospho-Ser34 motif as the recognition element and providing an atomic-resolution view of a regulatory contact.

   Evidence X-ray crystallography (PDB 3UAL) and isothermal titration calorimetry

   PMID:22151054

   Open questions at the time

   • Cellular consequence of 14-3-3ε binding to human MLF1 not established
   • Kinase responsible for Ser34 phosphorylation unknown
8. 2012 Medium

   Showed that, unlike mouse MLF1, human MLF1 localization is independent of 14-3-3 binding, indicating species-specific regulation and pointing to additional unidentified localization determinants.

   Evidence Live-cell imaging of GFP-fused human MLF1 with 14-3-3 binding-site mutants and deletions

   PMID:23271436

   Open questions at the time

   • Identity of the proteins controlling human MLF1 localization unknown
   • Negative result from a single method and lab
9. 2015 Low

   Linked MLF1 to the chaperone MRJ/DNAJB6 and showed that muscle overexpression produces benign aggregates, addressing whether MLF1 aggregation is intrinsically pathogenic.

   Evidence Co-interaction assay and transgenic mouse muscle with histology and RotaRod testing

   PMID:17854834

   Open questions at the time

   • Interaction reported without detailed method and not independently validated
   • No demonstrated pathological consequence of aggregation
   • Functional significance of the MRJ interaction unclear
10. 2017 High

    Established a mitochondrial pro-apoptotic mechanism whereby MLF1 binds HAX1 and HtrA2 to displace HtrA2 from the pro-survival HOP complex, validated in vivo by genetic epistasis showing Mlf1 deletion rescues Hax1-/- pathology and doubles lifespan.

    Evidence Reciprocal co-immunoprecipitation, overexpression/knockdown, and Mlf1-/-/Hax1-/- double-knockout mice

    PMID:28137643

    Open questions at the time

    • Signals that drive MLF1 to mitochondria not defined
    • Integration with nuclear/p53 functions of MLF1 unresolved
11. 2019 Medium

    Connected NPM-MLF1 oncogenesis to chromatin regulation by showing the fusion interacts with ISWI, NuRD, and P/BAF subunits and enhances NuRD recruitment to gene regulatory regions, providing a transcriptional mechanism for leukemogenesis.

    Evidence Mass spectrometry interactome, ChIP, and gene expression analysis in NPM knockdown and NPM-MLF1 expressing cells

    PMID:31675375

    Open questions at the time

    • Direct transcriptional targets driving transformation not pinpointed
    • Whether native MLF1 engages these complexes not addressed
12. 2025 High

    Defined native MLF1 as a chromatin-acting transcriptional activator that recruits EP300 to deposit H3K27ac and open chromatin at senescence loci, establishing a direct, EP300-dependent epigenetic mechanism for its nuclear function.

    Evidence RNA-seq, ATAC-seq, CUT&Tag, knockdown/overexpression in AC16 cardiomyocytes, and EP300/PRC2 inhibitor epistasis

    PMID:39657728

    Open questions at the time

    • Mechanism of MLF1 promoter targeting (sequence specificity or partner-mediated) not defined
    • Relationship between this EP300 activity and the cytoplasmic/mitochondrial MLF1 functions unresolved

• How MLF1's distinct cytoplasmic, mitochondrial, and chromatin-associated activities are coordinated by its shuttling and what signals partition it among compartments remain unresolved.
• No unified model linking p53 stabilization, EP300-driven transcription, and HOP-complex apoptosis
• Determinants of human MLF1 nuclear import unidentified
• Direct DNA/promoter-recognition mechanism unknown